Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Early initiation of antiretroviral therapy following in utero HIV infection is associated with low viral reservoirs but other factors determine subsequent plasma viral rebound.
ABX464 decreases the total HIV reservoir and HIV transcription initiation in CD4 + T cells from HIV-infected ART-suppressed individuals.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Motivations, barriers and experiences of participants in an HIV reservoir trial.
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.
Erratum for Puertas et al., "VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies".
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.